NO922968D0 - Peptidylderivater - Google Patents
PeptidylderivaterInfo
- Publication number
- NO922968D0 NO922968D0 NO922968A NO922968A NO922968D0 NO 922968 D0 NO922968 D0 NO 922968D0 NO 922968 A NO922968 A NO 922968A NO 922968 A NO922968 A NO 922968A NO 922968 D0 NO922968 D0 NO 922968D0
- Authority
- NO
- Norway
- Prior art keywords
- group
- alkyl
- amino
- alkenyl
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909026251A GB9026251D0 (en) | 1990-12-03 | 1990-12-03 | Netalloproteinase inhibitors |
GB919110339A GB9110339D0 (en) | 1991-05-13 | 1991-05-13 | Metalloproteinase inhibitors |
GB919110338A GB9110338D0 (en) | 1991-05-13 | 1991-05-13 | Metalloproteinase inhibitors |
GB919112901A GB9112901D0 (en) | 1991-06-14 | 1991-06-14 | Metalloproteinase inhibitors |
GB919112888A GB9112888D0 (en) | 1991-06-14 | 1991-06-14 | Metalloproteinase inhibitors |
GB919115038A GB9115038D0 (en) | 1991-07-11 | 1991-07-11 | Metalloproteinase inhibitors |
GB919115039A GB9115039D0 (en) | 1991-07-11 | 1991-07-11 | Metalloproteinase inhibitors |
GB919115916A GB9115916D0 (en) | 1991-07-23 | 1991-07-23 | Metalloproteinase inhibitors |
PCT/GB1991/002143 WO1992009565A1 (en) | 1990-12-03 | 1991-12-03 | Peptidyl derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO922968D0 true NO922968D0 (no) | 1992-07-28 |
NO922968L NO922968L (no) | 1992-09-24 |
Family
ID=27571285
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92922968A NO922968L (no) | 1990-12-03 | 1992-07-28 | Peptidylderivater |
NO92922967A NO922967L (no) | 1990-12-03 | 1992-07-28 | Peptidylderivater |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92922967A NO922967L (no) | 1990-12-03 | 1992-07-28 | Peptidylderivater |
Country Status (16)
Country | Link |
---|---|
US (1) | US5300501A (no) |
EP (2) | EP0489579B1 (no) |
JP (2) | JPH05503719A (no) |
KR (2) | KR927003520A (no) |
AT (2) | ATE120451T1 (no) |
AU (2) | AU652596B2 (no) |
CA (2) | CA2073510A1 (no) |
DE (2) | DE69108363T2 (no) |
DK (1) | DK0489579T3 (no) |
ES (1) | ES2069833T3 (no) |
FI (2) | FI923494A0 (no) |
GB (2) | GB2255339B (no) |
GR (1) | GR3015567T3 (no) |
HU (3) | HUT62263A (no) |
NO (2) | NO922968L (no) |
WO (2) | WO1992009564A1 (no) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
EP0520573A1 (en) * | 1991-06-27 | 1992-12-30 | Glaxo Inc. | Cyclic imide derivatives |
AU3899193A (en) * | 1992-04-07 | 1993-11-08 | British Bio-Technology Limited | Hydroxamic acid based collagenase and cytokine inhibitors |
GB9211707D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
GB9211706D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
AU5292193A (en) * | 1992-10-02 | 1994-04-26 | Merck & Co., Inc. | N-(mercaptoacyl)peptidyl derivatives as antidegenerative agents |
US6090785A (en) * | 1992-10-15 | 2000-07-18 | Merck & Co., Inc. | Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents |
GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
US5672583A (en) * | 1992-11-25 | 1997-09-30 | Merck & Co., Inc. | Carboxy-peptidyl derivatives as antidegenerative active agents |
US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5652262A (en) * | 1993-03-16 | 1997-07-29 | British Biotech Pharmaceutical, Ltd. | Hydroxamic acid derivatives as metalloproteinase inhibitors |
WO1994022309A1 (en) * | 1993-04-07 | 1994-10-13 | Glycomed Incorporated | Synthetic matrix metalloprotease inhibitors and uses thereof |
GB9307956D0 (en) * | 1993-04-17 | 1993-06-02 | Walls Alan J | Hydroxamic acid derivatives |
US5714491A (en) * | 1993-04-27 | 1998-02-03 | Celltech Therapeutics Limited | Peptidyl derivatives as metalloproteinase inhibitors |
GB9308695D0 (en) * | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
DE69415159T2 (de) * | 1993-08-02 | 1999-07-22 | Celltech Therapeutics Ltd | Succinamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als gelatinase- und collagenase- inhibitoren |
US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
GB9320660D0 (en) * | 1993-10-07 | 1993-11-24 | British Bio Technology | Inhibition of cytokine production |
US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
NZ278627A (en) * | 1994-01-20 | 1997-04-24 | British Biotech Pharm | Carboxylic and hydroxamic acid derivatives and pharmaceutical compositions |
US5514716A (en) * | 1994-02-25 | 1996-05-07 | Sterling Winthrop, Inc. | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
DE69510198T2 (de) * | 1994-05-28 | 1999-10-28 | British Biotech Pharm | Succinyl hydroxamsäure-, n-formyl-n-hydroxy-aminocarbonsäure- und succinsäureamid-derivate und ihre verwendung als metalloprotease-inhibitoren |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
ATE191468T1 (de) * | 1994-06-22 | 2000-04-15 | British Biotech Pharm | Metalloproteinase inhibitoren |
US5840698A (en) * | 1994-10-27 | 1998-11-24 | Affymax Technologies N.V. | Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use |
US5831004A (en) * | 1994-10-27 | 1998-11-03 | Affymax Technologies N.V. | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5919940A (en) * | 1995-01-20 | 1999-07-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
US5857961A (en) * | 1995-06-07 | 1999-01-12 | Clarus Medical Systems, Inc. | Surgical instrument for use with a viewing system |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
IT1277904B1 (it) * | 1995-08-07 | 1997-11-12 | Polifarma Spa | Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego |
US5665777A (en) * | 1995-11-14 | 1997-09-09 | Abbott Laboratories | Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
ES2164264T3 (es) * | 1995-11-23 | 2002-02-16 | British Biotech Pharm | Inhibidores de metaloproteinasas. |
IL138027A (en) * | 1995-12-08 | 2004-08-31 | Agouron Pharma | Intermediates for the preparation and preparation of metalloproteinase inhibitors |
US6500948B1 (en) | 1995-12-08 | 2002-12-31 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
GB9613547D0 (en) * | 1996-06-27 | 1996-08-28 | Pharmacia Spa | Matrix metalloproteinase inhibitors |
CA2265666C (en) | 1996-09-10 | 2008-01-15 | British Biotech Pharmaceuticals Limited | Cytostatic hydroxamic acid derivatives |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
US6174915B1 (en) | 1997-03-25 | 2001-01-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6008243A (en) * | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
JPH10130217A (ja) * | 1996-11-01 | 1998-05-19 | Kotobuki Seiyaku Kk | カルボン酸及びその誘導体及びその製造法並びにこれを含有する医薬組成物 |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
ZA9818B (en) * | 1997-01-07 | 1998-07-02 | Abbott Lab | C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
EP0887077A1 (de) * | 1997-06-27 | 1998-12-30 | Roche Diagnostics GmbH | Verwendung von Azulenderivaten als Metalloproteaseinhibitoren |
GB9803005D0 (en) | 1998-02-12 | 1998-04-08 | British Biotech Pharm | Anti-inflammatory agents |
GB9804504D0 (en) * | 1998-03-03 | 1998-04-29 | Leo Pharm Prod Ltd | Matrix metalloproteinase inhibitors |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
JP2001031637A (ja) * | 1999-05-17 | 2001-02-06 | Fuji Chemical Industries Ltd | 新規なヒドロキサム酸誘導体 |
MXPA01011762A (es) * | 1999-05-17 | 2002-04-24 | Daiichi Fine Chem Co Ltd | Derivados novedosos de acido hidroxamico. |
PE20010659A1 (es) | 1999-10-01 | 2001-06-20 | Hoffmann La Roche | Derivados de las pirimidin-2,4,6-trionas como inhibidores de metaloproteasas |
US6797820B2 (en) | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
WO2002006227A1 (fr) * | 2000-07-18 | 2002-01-24 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de la metalloprotease matricielle |
US6716845B2 (en) | 2001-03-30 | 2004-04-06 | Hoffmann-La Roche Inc. | Barbituric acid derivatives |
CA2446931A1 (en) | 2001-06-15 | 2002-12-27 | Vicuron Pharmaceuticals Inc. | Pyrrolidine bicyclic compounds |
AR036053A1 (es) | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
US7605132B2 (en) * | 2001-08-29 | 2009-10-20 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Protective factors against inflammation, burns and noxious stimuli |
WO2005090387A2 (en) * | 2004-03-23 | 2005-09-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Histone h2a peptide derivatives and analogs and methods of use thereof |
US7528227B2 (en) | 2004-03-23 | 2009-05-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Histone H2A peptide derivatives and uses thereof |
JP2006516252A (ja) * | 2002-12-27 | 2006-06-29 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | コラーゲンおよびmmpiを用いる組成物および方法 |
GB0818907D0 (en) * | 2008-10-15 | 2008-11-19 | Isis Innovation | Histone lysine demethylase inhibitors |
EP2416799B1 (en) | 2009-04-10 | 2017-11-01 | Tufts Medical Center, Inc. | Par-1 activation by metalloproteinase-1 (mmp-1) |
DE102014206916A1 (de) | 2014-04-10 | 2015-10-15 | Wacker Chemie Ag | Verfahren zur Ruthenium-katalysierten Umvinylierung von Carbonsäuren |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
US5196412A (en) * | 1991-03-06 | 1993-03-23 | Johnson Matthey, Inc. | Gallium compounds |
-
1991
- 1991-12-03 WO PCT/GB1991/002142 patent/WO1992009564A1/en active Application Filing
- 1991-12-03 EP EP91311254A patent/EP0489579B1/en not_active Expired - Lifetime
- 1991-12-03 AT AT91311254T patent/ATE120451T1/de not_active IP Right Cessation
- 1991-12-03 HU HU922497A patent/HUT62263A/hu unknown
- 1991-12-03 CA CA002073510A patent/CA2073510A1/en not_active Abandoned
- 1991-12-03 EP EP91311252A patent/EP0489577B1/en not_active Expired - Lifetime
- 1991-12-03 US US07/916,108 patent/US5300501A/en not_active Expired - Lifetime
- 1991-12-03 HU HU9202498A patent/HUT61973A/hu unknown
- 1991-12-03 AU AU90233/91A patent/AU652596B2/en not_active Ceased
- 1991-12-03 JP JP4500488A patent/JPH05503719A/ja active Pending
- 1991-12-03 HU HU922497Q patent/HU9202497D0/hu unknown
- 1991-12-03 AU AU90173/91A patent/AU652793B2/en not_active Ceased
- 1991-12-03 ES ES91311254T patent/ES2069833T3/es not_active Expired - Lifetime
- 1991-12-03 KR KR1019920701787A patent/KR927003520A/ko not_active Application Discontinuation
- 1991-12-03 DE DE69108363T patent/DE69108363T2/de not_active Expired - Fee Related
- 1991-12-03 AT AT91311252T patent/ATE120182T1/de active
- 1991-12-03 WO PCT/GB1991/002143 patent/WO1992009565A1/en active Application Filing
- 1991-12-03 CA CA002073513A patent/CA2073513A1/en not_active Abandoned
- 1991-12-03 DE DE69108529T patent/DE69108529T2/de not_active Expired - Fee Related
- 1991-12-03 DK DK91311254.6T patent/DK0489579T3/da active
- 1991-12-03 JP JP4500489A patent/JPH05503720A/ja active Pending
- 1991-12-03 KR KR1019920701788A patent/KR927003521A/ko not_active Application Discontinuation
-
1992
- 1992-06-02 GB GB9211714A patent/GB2255339B/en not_active Expired - Fee Related
- 1992-06-02 GB GB9211715A patent/GB2255340B/en not_active Expired - Fee Related
- 1992-07-28 NO NO92922968A patent/NO922968L/no unknown
- 1992-07-28 NO NO92922967A patent/NO922967L/no unknown
- 1992-08-03 FI FI923494A patent/FI923494A0/fi not_active Application Discontinuation
- 1992-08-03 FI FI923495A patent/FI923495A/fi not_active Application Discontinuation
-
1995
- 1995-03-30 GR GR940403917T patent/GR3015567T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69108529T2 (de) | Peptidylderivate. | |
AU645867B2 (en) | 2-arylthiazole derivative and pharmaceutical composition containing the same | |
ATE71372T1 (de) | Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel. | |
DE69718306D1 (de) | Piperidinylpyrimidine derivate | |
DK0487620T3 (da) | Hidtil ukendte aminosyrederivater, fremgangsmåde til fremstilling heraf og terapeutisk anvendelse heraf | |
ES8702379A1 (es) | Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas. | |
DE59915244D1 (de) | Kosmetische oder pharmazeutische Zubereitungen enthaltend 1,3,5-Triazinderivate und Zinkoxid | |
ES2012958A6 (es) | Procedimiento para preparar derivados de cisteina. | |
DK363284D0 (da) | Endo-8,8-dialkyl-8-azoniabicyclo/3.2.1/octan-6,7-exo-epoxy-3-alkylcarboxylatsalte, fremgangsmaade til fremstilling heraf og terapeutiske praeparater indeholdende disse | |
DE3861545D1 (de) | Aminoverbindungen und diese enthaltende fungizide. | |
MD122C2 (ro) | Procedeu de obţinere a derivaţilor oxadiazolilalchilpurinei sau a sărurilor ei acide aditive farmacologic acceptabile | |
AU4878479A (en) | Clavulanic acid derivatives |